Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
Condition(s):HIV Infection; Liver Failure; Evidence of Liver TransplantationLast Updated:July 18, 2013Completed
Hide Studies Not Open or Pending
Condition(s):HIV Infection; Liver Failure; Evidence of Liver TransplantationLast Updated:July 18, 2013Completed
Condition(s):HIV InfectionsLast Updated:March 21, 2017Completed
Condition(s):HIVLast Updated:January 10, 2019Completed
Condition(s):HIV Infections; AIDSLast Updated:May 30, 2017Completed
Condition(s):AIDSLast Updated:June 30, 2016Unknown status
Condition(s):Human Immunodeficiency Virus InfectionLast Updated:February 14, 2012Completed
Condition(s):HIV; HIV-associated Neurocognitive Disorder; NeurotoxicityLast Updated:July 26, 2017Completed
Condition(s):HIV-1 InfectionLast Updated:August 2, 2019Completed
Condition(s):Calcium Supplementation in HIV Patients Using RaltegravirLast Updated:December 12, 2023Recruiting
Condition(s):HIV-1 Infection; HIV InfectionsLast Updated:February 8, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.